| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 03/10/1992 | US5095006 Renin inhibitors having all retro-inverted peptide bonds |
| 03/10/1992 | CA1297128C Bis(cyclopropanecarboxamido) alkadienedioic acids as renal dipeptidase inhibitors |
| 03/10/1992 | CA1297127C2 Polycyclical aromatic derivatives and cosmetic use |
| 03/10/1992 | CA1297111C .alpha.-ALKYL-4-AMINO-3-QUINOLINEMETHANOLS AND 1-(4- ARALKYL-AMINO-3-QUINOLINYL)ALKANONES, A PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS |
| 03/10/1992 | CA1297106C Antiallergic agents and process for their preparation |
| 03/10/1992 | CA1297034C Liquid calcium supplementation from readily soluble mixtures of calciumcompound and citric acid |
| 03/10/1992 | CA1297026C Brompheniramine, pseudoephedrine therapy |
| 03/10/1992 | CA1297024C Drug compositions stabilized against oxidation |
| 03/10/1992 | CA1297023C Stabilized drug composition containing ascorbic acid |
| 03/08/1992 | WO1992004310A1 Triarylethylene carboxylic acids with estrogenic activity |
| 03/08/1992 | CA2089373A1 Triarylethylene carboxylic acids with estrogenic activity |
| 03/05/1992 | WO1992004015A2 REGULATION OF T-CELL PROLIFERATION VIA A NOVEL 5HT1a RECEPTOR |
| 03/05/1992 | WO1992004014A2 REGULATION OF NEOPLASTIC CELL PROLIFERATION VIA A NOVEL 5HT1a RECEPTOR |
| 03/05/1992 | WO1992003472A1 Peptides containing amino-polyols as transition-state mimics |
| 03/05/1992 | WO1992003467A1 Transferrin binding proteins from neisseria gonorrhoeae and neisseria meningitidis |
| 03/05/1992 | WO1992003451A1 Bisphosphonic acid derivatives as anti-arthritic agents |
| 03/05/1992 | WO1992003433A1 Heterocyclic compounds and their preparation and use |
| 03/05/1992 | WO1992003431A1 Heterocyclic compounds and their preparation and use |
| 03/05/1992 | WO1992003430A1 Heterocyclic compounds and their preparation and use |
| 03/05/1992 | WO1992003422A1 Benzimidazole derivatives, process for their preparation and their application |
| 03/05/1992 | WO1992003414A1 Novel vitamin d analogues |
| 03/05/1992 | WO1992003154A1 Product and use of it for the treatment of catabolic states comprising authentic igf-1 and hypocaloric amount of nutritients |
| 03/05/1992 | WO1992003151A1 Uses of recombinant colony stimulating factor-1 |
| 03/05/1992 | WO1992003146A1 Therapeutically active mixture of glutathion and anthocyan compounds |
| 03/05/1992 | WO1992003139A1 Oligonucleotide modulation of cell adhesion |
| 03/05/1992 | CA2090689A1 Regulation of t-cell proliferation via a novel 5htla receptor |
| 03/05/1992 | CA2090688A1 Regulation of neoplastic cell proliferation via a novel 5htla receptor |
| 03/05/1992 | CA2089770A1 Heterocyclic compounds and their preparation and use |
| 03/05/1992 | CA2088674A1 Product and use of it for the treatment of catabolic states comprising authentic igf-1 and hypocaloric amount of nutrients |
| 03/05/1992 | CA2050537A1 Hmg-coa reductase inhibitor metabolites |
| 03/05/1992 | CA2050434A1 Renin inhibitors |
| 03/04/1992 | EP0473308A1 Aldose reductase inhibitor |
| 03/04/1992 | EP0473252A2 Use of L-deprenyl for retarding deterioration due to aging in dogs |
| 03/04/1992 | EP0473080A2 Chondromodulin-I protein |
| 03/04/1992 | EP0198893B1 Hair growth modification |
| 03/04/1992 | EP0180597B1 Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs |
| 03/04/1992 | CN1059143A Pyrazolopyridine compound and process for prepn. thereof |
| 03/04/1992 | CN1059141A 苯并二氮杂衍生物 Benzodiazepine derivative |
| 03/03/1992 | US5093507 Estrenes, antiglucocorticoid, antiestrogen |
| 03/03/1992 | US5093363 2,4,6-substituted phenol derivatives |
| 03/03/1992 | US5093351 Substituted indole, benzofuran and benzothiophene derivatives as 5-lipoxygenase inhibitors |
| 03/03/1992 | US5093350 Dehydrocycloclausenamide, its preparation and use in treating cerebral hypoxia |
| 03/03/1992 | US5093339 Anticoagulant, hypotensive, antiangina, antiasthma, antiulcer, anti-platelet activating factor |
| 03/03/1992 | US5093315 Aqueous solutions or solids |
| 03/03/1992 | CA1296740C 4-hydroxy-4-(substituted alkenyl)cyclohexanecarboxylic acids |
| 03/03/1992 | CA1296739C Diphosphonic acid derivatives, processes for the preparation thereofand pharmaceutical compositions containing them |
| 03/03/1992 | CA1296731C 5-phenyl-1,4-dihydropyridines, process for their preparation and their use in medicaments |
| 03/03/1992 | CA1296716C N-(2-substituted alkyl)-n'-[(imidazole-4-yl) alkyl] guanidine |
| 03/03/1992 | CA1296633C Controlled release bases for pharmaceuticals |
| 03/01/1992 | WO1992004338A1 Tropolone derivatives and pharmaceutical composition thereof for preventing and treating ischemic diseases |
| 03/01/1992 | WO1992004024A2 Toxic agent protective compounds, compositions and method |
| 03/01/1992 | WO1992003152A1 New insulin-like growth factor binding protein (igfbp-4) |
| 03/01/1992 | CA2090703A1 Insulin-like growth factor binding protein (igfbp-4) |
| 03/01/1992 | CA2089158A1 Toxic agent protective compounds, compositions and method |
| 03/01/1992 | CA2049803A1 Serotonin 5ht1a agonists |
| 02/28/1992 | WO1992003459A1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF |
| 02/28/1992 | CA2090469A1 Ligand for the c-kit receptor and methods of use thereof |
| 02/28/1992 | CA2049902A1 Method for treating inflammation, ischemia-induced cell damage and muscular distrophy |
| 02/26/1992 | EP0472449A2 Substituted sulfonamides, processes for their preparation and medicines containing them |
| 02/26/1992 | EP0472220A1 Bradykinin antagonists |
| 02/26/1992 | EP0472011A1 Composition containing protease produced by vibrio and method of use in debridement and wound healing |
| 02/26/1992 | EP0471793A1 Improved forms of basic fibroblast growth factor |
| 02/26/1992 | EP0471787A1 A plasmid dna construct including the gene encoding a mammalian beta-nerve growth factor |
| 02/26/1992 | EP0471750A1 Heterocyclic n-oxide derivatives of substituted benzo 5,6]cycloheptapyridines, compositions and methods of use |
| 02/26/1992 | CN1058965A Process for preparing quinoline derivatives |
| 02/26/1992 | CN1058962A 6-substituted-hexahydrobenz(cd)indoles |
| 02/26/1992 | CN1058961A 6-substituted-tetrahydrobenz(cd)indoles |
| 02/25/1992 | US5091569 Di-tert-butyl(hydroxy)phenylthio substituted hydroxamic acid derivatives |
| 02/25/1992 | US5091528 6- or 7- (2-imino-2-imidazolidine)-1,4-benzoxazines as α adrenergic agents |
| 02/25/1992 | US5091510 Retro-inverso analogues of thymopentin, and their use in the preparation of pharmaceutical compositions |
| 02/25/1992 | US5091418 Novel alpha-glucosidase inhibitor, pradimicin Q |
| 02/25/1992 | US5091417 Preventive and therapeutic agent for hepatitis |
| 02/25/1992 | US5091415 Thioformamidines, their preparation and use as medicaments |
| 02/25/1992 | US5091392 Substituted (quinolin-2-yl-methoxy)phenyl-acyl-sulphon-amides and -cyanamides, processes for their preparation and their use in medicaments |
| 02/25/1992 | US5091386 7-substituted derivatives of 3,5-dihydroxyhept-6-ynoic acids and corresponding lactones and their use as hypercholeserolemics |
| 02/25/1992 | US5091380 N-monosubstituted adamantyl/norbornanyl 17β-carbamides of 3-carboxy-androst-3,5-dienes as testosterone 5α-reductase inhibitors |
| 02/25/1992 | US5091365 Cyclic peptides as promoters of absorption on administration onto the mucosa |
| 02/25/1992 | CA2049743A1 Bradykinin antagonists |
| 02/25/1992 | CA1296342C Anti-inflammatory agents, pharmaceutical compositions and methods for reducing inflammation |
| 02/25/1992 | CA1296341C Substituted di-t-butylphenols |
| 02/25/1992 | CA1296339C Antihyperlipidemic and antiatherosclerotic urea and carbamate compounds |
| 02/25/1992 | CA1296337C Substituted 8-(phenylthio)-tetrahydroquinolines useful in the treatment of allergy |
| 02/25/1992 | CA1296273C Recombinant methods for production of serine protease inhibitors and methods for isolation of same |
| 02/24/1992 | CA2049538A1 Chondromodulin-i protein |
| 02/21/1992 | WO1992003132A1 Indole derivatives which inhibit leukotriene biosynthesis |
| 02/21/1992 | CA2090006A1 Indole derivatives which inhibit leukotriene biosynthesis |
| 02/20/1992 | WO1992002539A1 Process for the enzymatic preparation of basic fibroblast growth factor |
| 02/20/1992 | WO1992002515A1 (2-imidazolin-2-ylamino) quinoxaline derivatives and methods for using same |
| 02/20/1992 | WO1992002508A1 Process for the manufacture of quinoline derivatives |
| 02/20/1992 | WO1992002242A1 Use of metalloporphyrins to potentiate aids therapy |
| 02/20/1992 | WO1992002238A1 Tissue bonding and sealing composition and method of using the same |
| 02/20/1992 | WO1992002221A1 Use of 2-phenyl-1,2-benzisoselenazol-3(2h)-one |
| 02/20/1992 | WO1992002214A1 Aica riboside analogs |
| 02/20/1992 | WO1992000276A3 Angiotensis converting enzyme inhibitors |
| 02/20/1992 | CA2088593A1 Use of metalloporphyrins to potentiate aids therapy |
| 02/19/1992 | EP0471609A1 Benzofuran Derivatives, Benzothiophenes, Indoles or Indolizines, Process for Production and Compositions containing them |
| 02/19/1992 | EP0471576A1 6-substituted-tetrahydrobenz[cd]indoles |
| 02/19/1992 | EP0471569A1 6-Substituted-hexahydrobenz (CD) indoles |
| 02/19/1992 | EP0471525A1 Use of a pure narcotic antagonist, e.g. nalmefene, naltrexone, naloxone or diprenorphine, in the treatment of mast cell disease |
| 02/19/1992 | EP0471259A1 Phenylsulfonamid substituted pyridinealken- and aminooxyalkan-carboxylic-acid derivatives |